Philip Robson

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

Philip McGuire, Philip Robson, D. Vasile et al. · American Journal of Psychiatry · 2017 · 593 citations · Full text

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

Derick T Wade, Petra Mäkelä, Philip Robson et al. · Multiple Sclerosis Journal · 2004 · 579 citations

Neurological Disorder, Pharmacotherapy, Matched Placebo +17

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

Derick T Wade, Philip Robson, Heather House et al. · Clinical Rehabilitation · 2003 · 432 citations

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis

David R. Blake, Philip Robson, Madeline Ho et al. · Lara D. Veeken · 2005 · 410 citations · Full text

Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

Anthony N. Nicholson, Claire Turner, Barbara M. Stone et al. · Journal of Clinical Psychopharmacology · 2004 · 286 citations